Sign In
Buy ARNA
$99.99
+0 (+0%)
At Close: May 27, 2022
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q1 2020 Results - Earnings Call Transcript
01:36am, Friday, 08'th May 2020
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Q1 2020 Results Conference Call May 7, 2020 4:30 PM ET Company Participants Laurie Stelzer - CFO Amit Munshi - Preside
Cantor Fitzgerald Reiterates Overweight on Arena Pharmaceuticals, Raises Price Target to $68
12:00am, Friday, 08'th May 2020Arena Announces Corporate Update and Reports First Quarter 2020 Financial Results
08:01pm, Thursday, 07'th May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2020.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Arena Pharmaceuticals to Present at the Bank of America Securities Healthcare Conference on May 13
12:30pm, Wednesday, 06'th May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Preston Klassen, MD, MHS, the Company's Executive Vice President, Head of Research & Development, is scheduled to participate in a virtu
Stocks Showing Improving Market Leadership: Arena Pharmaceuticals Earns 85 RS Rating
12:00am, Tuesday, 05'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Arena Pharmaceuticals to Release First Quarter 2020 Financial Results and Provide Corporate Update on May 7
12:30pm, Thursday, 30'th Apr 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2020 financial results and provide a corporate update on Thursday, May 7, 2020, after the close of the U.S. financial markets.
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
12:00pm, Thursday, 30'th Apr 2020
United Therapeutics (UTHR) beats estimates for both earnings and sales in first quarter. It expects a reduction in new patient starts in the future quarters. Stock down.
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
12:00pm, Thursday, 30'th Apr 2020
United Therapeutics (UTHR) beats estimates for both earnings and sales in first quarter. It expects a reduction in new patient starts in the future quarters. Stock down.
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
12:00am, Thursday, 30'th Apr 2020Arena Pharmaceuticals (NASDAQ:ARNA) Stock Price Passes Above 200-Day Moving Average of $46.90
10:00am, Tuesday, 28'th Apr 2020
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $46.90 and traded as high as $53.00. Aren
How this Week’s Premium Top 10 Performed, April 24, 2020
08:13pm, Friday, 24'th Apr 2020
How this Week’s Premium Top 10 Performed, April 24, 2020
Posted by
Greg Harmon
on April 24th, 2020
Each week I post the performance of the stocks that were given to subscribers the previous Sunday.
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01:00pm, Friday, 24'th Apr 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on April 15, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 39,
